Gemini Therapeutics, Inc.
(NASDAQ) GMTX
Gemini Therapeutics, Inc. Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$212.18
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
GMTX News
GMTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Gemini Therapeutics, Inc.
Industry
Biotechnology
Sector
Health CareEmployees
155
CEO
John D. Quisel, PhD
Website
www.discmedicine.comHeadquarters
Cambridge, MA 02139, US
GMTX Financials
Key Financial Metrics (TTM)
Gross Margin
N/A
Operating Margin
N/A
Net Income Margin
N/A
Return on Equity
N/A
Return on Capital
N/A
Return on Assets
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Payout Ratio
N/A
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
N/A
Operating Income
N/A
EBITDA
N/A
Operating Cash Flow
N/A
Capital Expenditure
N/A
Free Cash Flow
N/A
Cash & ST Invst.
N/A
Total Debt
N/A
Gemini Therapeutics, Inc. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.09
+9.9%
Gross Margin
N/A
N/A
Market Cap
N/A
N/A
Market Cap/Employee
$19.34
+0.8%
Employees
155
+2.0%
Net Income
$60.53
+2.1%
EBITDA
$66.88
+1.9%
Quarterly Fundamentals
Net Cash
$81.16
+0.8%
Accounts Receivable
N/A
N/A
Inventory
$0.00
N/A
Long Term Debt
$30.41
+1.0%
Short Term Debt
$0.61
+4.7%
Return on Assets
-32.55%
+1.3%
Return on Invested Capital
24.89%
+0.7%
Free Cash Flow
$43.32
+1.5%
Operating Cash Flow
$43.30
+1.6%